GENORAY Co., Ltd. is a digital X-ray specialist established in 2001, engaged in the research, development, manufacturing, and sales of various medical imaging diagnostic equipment. Its product portfolio includes C-Arms for surgery, mammography systems, 3D CTs, panoramic X-rays, and portable X-ray units. The company has revolutionized medical and dental imaging environments through the supply of surgical C-Arms to local hospitals, portable dental X-rays, and innovative panoramic systems equipped with direct-type sensors. GENORAY is a global healthcare company committed to continuous improvement and innovation in medical and dental digital imaging equipment.GENORAYCo.,Ltd.isadigitalX-rayspecialistestablishedin2001,engagedintheresearch,development,manufacturing,andsalesofvariousmedicalimagingdiagnosticequipment.ItsproductportfolioincludesC-Armsforsurgery,mammographysystems,3DCTs,panoramicX-rays,andportableX-rayunits.ThecompanyhasrevolutionizedmedicalanddentalimagingenvironmentsthroughthesupplyofsurgicalC-Armstolocalhospitals,portabledentalX-rays,andinnovativepanoramicsystemsequippedwithdirect-typesensors.GENORAYisaglobalhealthcarecompanycommittedtocontinuousimprovementandinnovationinmedicalanddentaldigitalimagingequipment.
Key Products/TechnologiesKeyProducts/Technologies
C-Arm (Mobile X-ray Fluoroscopy System for Surgery): Models include ZEN-2090 Pro, ZEN-5000, ZEN-7000, OSCAR prime, OSCAR 15FD, BELLIGER ACE, and EZX-60. These systems feature 5.3kW high-frequency inverter generators, options for 9-inch or 12-inch Image Intensifiers, a 1K CCD camera, 150-180 degrees of orbital rotation, active air cooling systems, low dose modes, 10.4-inch touchscreens, DICOM 3.0 support, 120 kV / 45 mA high output, and 1K x 1K image resolution for high-performance diagnostic imaging.C-Arm(MobileX-rayFluoroscopySystemforSurgery):ModelsincludeZEN-2090Pro,ZEN-5000,ZEN-7000,OSCARprime,OSCAR15FD,BELLIGERACE,andEZX-60.Thesesystemsfeature5.3kWhigh-frequencyinvertergenerators,optionsfor9-inchor12-inchImageIntensifiers,a1KCCDcamera,150-180degreesoforbitalrotation,activeaircoolingsystems,lowdosemodes,10.4-inchtouchscreens,DICOM3.0support,120kV/45mAhighoutput,and1Kx1Kimageresolutionforhigh-performancediagnosticimaging.
Mammography Systems: MX-300, MX-600, DMX-600, and HESTIA models available. These systems offer Full Field Digital Mammography with 17x24cm or 24x30cm Flat Panel Detectors, 4.0kW HFG (HESTIA features an 8.0kW HFG), ASP (Auto Standard Exposure Positioning), AEC (Automatic Exposure Control) mode, and a Smart Compression system (up to 20kg) for patient comfort. HESTIA specifically incorporates 3D Digital Breast Tomosynthesis (DBT) technology for enhanced breast cancer diagnostic accuracy, utilizing a tungsten target and molybdenum/aluminum filters.MammographySystems:MX-300,MX-600,DMX-600,andHESTIAmodelsavailable.ThesesystemsofferFullFieldDigitalMammographywith17x24cmor24x30cmFlatPanelDetectors,4.0kWHFG(HESTIAfeaturesan8.0kWHFG),ASP(AutoStandardExposurePositioning),AEC(AutomaticExposureControl)mode,andaSmartCompressionsystem(upto20kg)forpatientcomfort.HESTIAspecificallyincorporates3DDigitalBreastTomosynthesis(DBT)technologyforenhancedbreastcancerdiagnosticaccuracy,utilizingatungstentargetandmolybdenum/aluminumfilters.
Dental X-ray Imaging Equipment: Panoramic & Ceph systems (PAPAYA PLUS, PAPAYA, PAPAYA 3D PLUS, PAPAYA 3D, PAPAYA 3D ENT, PAPAYA slim) provide low radiation exposure, multi-focus functionality, optional tomography imaging, various detector types, and user-friendly interfaces. Portable X-ray Systems (PORT X-III, PortView, PORT X-II (ZEN-PX2), Port X-IV) are characterized by lightweight and compact designs (Port X-IV at 1.5 kg), 60-70kV/2mA DC generators, 0.4-0.8mm focal spots, exposure times from 0.01-2.0 seconds, internal lead shielding, rechargeable lithium-polymer batteries (60-100 shots per charge), TWAIN software support, Wi-Fi dongles, and IPS LCD displays.DentalX-rayImagingEquipment:Panoramic&Cephsystems(PAPAYAPLUS,PAPAYA,PAPAYA3DPLUS,PAPAYA3D,PAPAYA3DENT,PAPAYAslim)providelowradiationexposure,multi-focusfunctionality,optionaltomographyimaging,variousdetectortypes,anduser-friendlyinterfaces.PortableX-raySystems(PORTX-III,PortView,PORTX-II(ZEN-PX2),PortX-IV)arecharacterizedbylightweightandcompactdesigns(PortX-IVat1.5kg),60-70kV/2mADCgenerators,0.4-0.8mmfocalspots,exposuretimesfrom0.01-2.0seconds,internalleadshielding,rechargeablelithium-polymerbatteries(60-100shotspercharge),TWAINsoftwaresupport,Wi-Fidongles,andIPSLCDdisplays.
ENT CT: VOLUX 9 ENT and PAPAYA 3D ENT models offer 3D CT imaging solutions specifically for ear, nose, and throat applications.ENTCT:VOLUX9ENTandPAPAYA3DENTmodelsoffer3DCTimagingsolutionsspecificallyforear,nose,andthroatapplications.
Software: ZENIS provides a total solution for C-Arm image acquisition, storage, management, and communication. TRIANA is a digital image management system compatible with PACS, capable of managing panoramic, cephalometric, CT, and portable sensor images. It includes a 3D Reconstruction Hive engine, MPR (Multi-Planar Reformatting), Dental Reformatting, and DICOM 3.0 support.Software:ZENISprovidesatotalsolutionforC-Armimageacquisition,storage,management,andcommunication.TRIANAisadigitalimagemanagementsystemcompatiblewithPACS,capableofmanagingpanoramic,cephalometric,CT,andportablesensorimages.Itincludesa3DReconstructionHiveengine,MPR(Multi-PlanarReformatting),DentalReformatting,andDICOM3.0support.
Core AdvantagesCoreAdvantages
Simultaneous Operation of Medical and Dental Businesses: The company is the only one in Korea to research, develop, manufacture, and sell both medical (hospital-use) and dental X-ray imaging diagnostic equipment. This enables synergy through the exchange of capabilities between different business areas and the ability to meet diverse medical needs.SimultaneousOperationofMedicalandDentalBusinesses:ThecompanyistheonlyoneinKoreatoresearch,develop,manufacture,andsellbothmedical(hospital-use)anddentalX-rayimagingdiagnosticequipment.Thisenablessynergythroughtheexchangeofcapabilitiesbetweendifferentbusinessareasandtheabilitytomeetdiversemedicalneeds.
Internalized Core Technology and Full Product Lineup: Internalization of core components and technologies, including X-ray generators, detectors, and image processing software, allows for a full lineup of high-quality imaging diagnostic equipment. This vertically integrated value chain, from R&D to manufacturing, sales, and customer support, ensures competitive pricing and strong market responsiveness.InternalizedCoreTechnologyandFullProductLineup:Internalizationofcorecomponentsandtechnologies,includingX-raygenerators,detectors,andimageprocessingsoftware,allowsforafulllineupofhigh-qualityimagingdiagnosticequipment.Thisverticallyintegratedvaluechain,fromR&Dtomanufacturing,sales,andcustomersupport,ensurescompetitivepricingandstrongmarketresponsiveness.
Global Market Competitiveness and Network: GENORAY maintains five overseas subsidiaries in the US, Germany, Japan, Turkey, and China, along with over 150 global partners for sales and service. The company exports its products to over 80 countries worldwide, with approximately 75% of its total revenue generated from international sales, highlighting its export-driven focus.GlobalMarketCompetitivenessandNetwork:GENORAYmaintainsfiveoverseassubsidiariesintheUS,Germany,Japan,Turkey,andChina,alongwithover150globalpartnersforsalesandservice.Thecompanyexportsitsproductstoover80countriesworldwide,withapproximately75%ofitstotalrevenuegeneratedfrominternationalsales,highlightingitsexport-drivenfocus.
Continuous R&D Investment and Innovative Product Launches: Annual investment of 8-10% of total revenue in R&D, leading to advancements in low-dose, high-resolution imaging technology. The company focuses on developing cutting-edge technologies like AI deep learning and automated diagnostic systems, exemplified by the launch of innovative products such as the DBT-certified mammography system 'HESTIA'.ContinuousR&DInvestmentandInnovativeProductLaunches:Annualinvestmentof8-10%oftotalrevenueinR&D,leadingtoadvancementsinlow-dose,high-resolutionimagingtechnology.Thecompanyfocusesondevelopingcutting-edgetechnologieslikeAIdeeplearningandautomateddiagnosticsystems,exemplifiedbythelaunchofinnovativeproductssuchastheDBT-certifiedmammographysystem'HESTIA'.
Dominant Domestic Market Share and Technological Leadership: GENORAY holds a commanding position as the number one company in the domestic C-Arm market, with over 70% market share. Its technological prowess, established since the development of Korea's first Mobile C-Arm product line in 2002, positions it as a leader in the medical industry.DominantDomesticMarketShareandTechnologicalLeadership:GENORAYholdsacommandingpositionasthenumberonecompanyinthedomesticC-Armmarket,withover70%marketshare.Itstechnologicalprowess,establishedsincethedevelopmentofKorea'sfirstMobileC-Armproductlinein2002,positionsitasaleaderinthemedicalindustry.
Target IndustriesTargetIndustries
Medical industry (orthopedics, neurosurgery, anesthesiology and pain medicine, cardiology, gastroenterology, oncology, general surgery, trauma, and various surgical environments)Medicalindustry(orthopedics,neurosurgery,anesthesiologyandpainmedicine,cardiology,gastroenterology,oncology,generalsurgery,trauma,andvarioussurgicalenvironments)
Dental industry (intraoral diagnosis and treatment)Dentalindustry(intraoraldiagnosisandtreatment)
Veterinary medicine (e.g., Oscar Classic C-arm)Veterinarymedicine(e.g.,OscarClassicC-arm)
Major MarketsMajorMarkets
Africa (including EMEA)Africa(includingEMEA)
Japan, ChinaJapan,China
Germany, Turkey, Europe (including EMEA)Germany,Turkey,Europe(includingEMEA)
United StatesUnitedStates
Brazil, Latin AmericaBrazil,LatinAmerica
Certifications/PatentsCertifications/Patents
Possession of 45-47 patents.Possessionof45-47patents.
Acquisition of 85 domestic and international medical device certifications (including FDA (US), MDD (Europe), PMDA (Japan), NMPA (China), ANVISA (Brazil)).Acquisitionof85domesticandinternationalmedicaldevicecertifications(includingFDA(US),MDD(Europe),PMDA(Japan),NMPA(China),ANVISA(Brazil)).
Re-certification as an 'Innovative Leading Medical Device Company' by the Ministry of Health and Welfare (2021).Re-certificationasan'InnovativeLeadingMedicalDeviceCompany'bytheMinistryofHealthandWelfare(2021).
Awarded the 'Export Tower' for $30 million (2019) and $50 million (2022) in exports by the Ministry of Trade, Industry and Energy.Awardedthe'ExportTower'for$30million(2019)and$50million(2022)inexportsbytheMinistryofTrade,IndustryandEnergy.
Selected as a 'KOSDAQ Rising Star' for four consecutive years (2023) by the Korea Exchange.Selectedasa'KOSDAQRisingStar'forfourconsecutiveyears(2023)bytheKoreaExchange.
PORT-X IV received 'Red Dot Awards' and 'Good Design' awards (2015).PORT-XIVreceived'RedDotAwards'and'GoodDesign'awards(2015).
Selected for the Excellent Technology Research Center (ATC) project (2015).SelectedfortheExcellentTechnologyResearchCenter(ATC)project(2015).
Awarded the Black Award at the 1st Design-Technology Innovation Awards (PAPAYA 3D) (2014).AwardedtheBlackAwardatthe1stDesign-TechnologyInnovationAwards(PAPAYA3D)(2014).
Selected for the '2023 Global Strong Small and Medium Enterprises 1000+ Project' by the Ministry of SMEs and Startups.Selectedforthe'2023GlobalStrongSmallandMediumEnterprises1000+Project'bytheMinistryofSMEsandStartups.